Article Details
Retrieved on: 2021-09-02 21:13:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies, one of the treatments promoted under the new staff funding plan, are designed to block COVID-19's attachment and entry into human cells.
Article found on: stateofreform.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here